薬剤溶出ステントの世界市場分析:ポリマー系コーティング別(非生分解性ポリマーベース、生分解性ポリマーベース)、ポリマーフリーコーティング別(マイクロポーラス表面、微細構造表面、スロット付き管状表面、ナノ多孔質表面)、用途別(冠動脈疾患、末梢動脈疾患)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Drug Eluting Stent Market, By Polymer-based Coatings (Non-biodegradable Polymer-based, Biodegradable Polymer-based), Polymer-free Coatings (Micro Porous Surface, Microstructured Surface, Slotted Tubular Surface, Nanoporous Surface), By Application (Coronary Artery Disease, Peripheral Artery Disease), And Segment Forecasts To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Executive Summary
Chapter 2 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market segmentation & scopes
3.1.1 Market Driver Analysis
3.1.2 Market Restraint Analysis
3.2 Penetration & growth prospect mapping
3.3 Drug Eluting Stents – SWOT Analysis, By Factor (political & legal, economic, and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Market Categorization 1: Drug Coating
4.1 Polymer-based Coatings
4.1.1 Non – biodegradable Polymers
4.1.2 Biodegradable Polymers
4.2 Polymer free Coatings
4.2.1 Micro porous Surface
4.2.2 Micro structured Surface
4.2.3 Slotted Tubular Surface
4.2.4 Nanoporous Surface
Chapter 5 Market Categorization 2: Application Outlook
5.1 Coronary Artery Disease
5.2 Peripheral Artery Disease
Chapter 6 Market Categorization 3: Regional Estimates & Trend Analysis, by Product
6.1 Drug Eluting Stent Market share by region, 2014 & 2024
6.2 North America market share by product, 2014 & 2024
6.2.1 U.S. market share by product, 2014 & 2024
6.2.2 Canada market share by product, 2014 & 2024
6.3 North America market share by application, 2014 & 2024
6.3.1 U.S. market share by application, 2014 & 2024
6.3.2 Canada market share by application, 2014 & 2024
6.4 Europe market share by product, 2014 & 2024
6.4.1 Germany market share by product, 2014 & 2024
6.4.2 U.K. market share by product, 2014 & 2024
6.5 Europe market share by application, 2014 & 2024
6.5.1 Germany market share by application, 2014 & 2024
6.5.2 U.K. market share by application, 2014 & 2024
6.6 Asia Pacific market share by product, 2014 & 2024
6.6.1 China market share by product, 2014 & 2024
6.6.2 Japan market share by product, 2014 & 2024
6.7 Asia Pacific market share by application, 2014 & 2024
6.7.1 China market share by application, 2014 & 2024
6.7.2 Japan market share by application, 2014 & 2024
6.8 Latin America market share by product, 2014 & 2024
6.8.1 Brazil market share by product, 2014 & 2024
6.8.2 Mexico market share by product, 2014 & 2024
6.9 Latin America market share by application, 2014 & 2024
6.9.1 Brazil market share by application, 2014 & 2024
6.9.2 Mexico market share by application, 2014 & 2024
6.10 MEA market share by product, 2014 & 2024
6.10.1 South Africa market share by product, 2014 & 2024
6.11 MEA market share by application, 2014 & 2024
6.11.1 South Africa market share by application, 2014 & 2024
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 Abbott Laboratories
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 Boston Scientific Corporation
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 Terumo Corporation
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Medtronic
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Biosensors International
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Cook Medical
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 Envision Scientific
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Biotronik
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Lepu Medical
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 Stentsys
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:薬剤溶出ステントの世界市場分析:ポリマー系コーティング別(非生分解性ポリマーベース、生分解性ポリマーベース)、ポリマーフリーコーティング別(マイクロポーラス表面、微細構造表面、スロット付き管状表面、ナノ多孔質表面)、用途別(冠動脈疾患、末梢動脈疾患)、セグメント予測
■ 英文:Drug Eluting Stent Market, By Polymer-based Coatings (Non-biodegradable Polymer-based, Biodegradable Polymer-based), Polymer-free Coatings (Micro Porous Surface, Microstructured Surface, Slotted Tubular Surface, Nanoporous Surface), By Application (Coronary Artery Disease, Peripheral Artery Disease), And Segment Forecasts To 2024
■ 発行日:2016年8月9日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707268
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。